Compare HUYA & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUYA | CLPT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 572.2M | 467.9M |
| IPO Year | 2018 | 2009 |
| Metric | HUYA | CLPT |
|---|---|---|
| Price | $2.05 | $13.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 1.5M | 490.6K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | ★ 81.37% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | $14.08 | $45.67 |
| Revenue Next Year | $6.11 | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $2.05 | $8.27 |
| 52 Week High | $4.93 | $30.10 |
| Indicator | HUYA | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 27.99 | 36.84 |
| Support Level | N/A | $12.47 |
| Resistance Level | $2.55 | $13.59 |
| Average True Range (ATR) | 0.06 | 0.82 |
| MACD | -0.00 | -0.22 |
| Stochastic Oscillator | 10.26 | 2.68 |
Huya officially became independent in 2016 and is headquartered in Guangzhou. It operates a live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. Huya is a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power, as of the end of 2025.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.